Dermipsor Obtains FDA Approval to Begin Phase II trials

26.11.2006 –

Chief Scientist Office to Invest additional NIS 1M in Dermipsor

27.09.06 – Company starts preparations for a clinical study

Dermipsor Appoints Prof. Mark Lebwohl and Prof. Alice B. Gottlieb to its Scientific Advisory Board

1.07.2006 – Key opinion leaders to asisst Dermipsor's clinical programs